Upneeq®, a company owned by RVL Pharmaceuticals, has launched a skincare treatment called Upneeq® Reveal Under Eye Complex, a fragrance-free formula that is designed to firm and smooth the under−eye area while supporting the skin barrier.
The product contains five percent stabilized vitamin C to help even out skin tone, alongside peptides, caffeine, creatine, and green tea actives to refresh tired−looking eyes. The Upneeq® Reveal Under Eye Complex also boasts soft-focus boosters that blur the appearance of fine lines and wrinkles, plus wheat germ oil and pomegranate sterols for nourishment.
Developed in collaboration with cosmetic chemist Ron Robinson and endorsed by board−certified oculoplastic surgeon Dr. Raymond Douglas, the formula has been tested by both dermatologists and ophthalmologists.
Fragrance-Free Under Eye Creams
Upneeq® Debuts the Upneeq Reveal Under Eye Complex
Trend Themes
-
Fragrance-free Specialty Skincare — Growing consumer demand for hypoallergenic, fragrance-free formulas is opening space for targeted products that reduce irritation while maintaining sensorial appeal through alternative textures and active combinations.
-
Eye-focused Functional Cosmetics — Formulations centered specifically on under-eye concerns are shifting the market toward multifunctional treatments that combine cosmetic blurring effects with measurable physiological benefits like firming and barrier support.
-
Clinical-collaboration Formulations — Partnerships between cosmetic chemists and medical specialists are enabling products that carry both aesthetic claims and clinician-backed credibility, blurring lines between beauty and medical-grade therapeutics.
Industry Implications
-
Dermocosmetics — The intersection of dermatology and beauty is primed for offerings that translate clinical actives into consumer-friendly formats with proven tolerability and visible results.
-
Ophthalmic Aesthetics — Procedures and topical products addressing periocular appearance are converging, creating opportunities for noninvasive solutions that complement surgical and minimally invasive eye-area treatments.
-
Ingredient Stabilization and Delivery — Advances in stabilizing sensitive actives like vitamin C and in targeted delivery systems are enabling longer-lasting efficacy in delicate areas, unlocking new product forms and claims.